Skip to main content
Download PDF
Download ePub

Erratum to: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation

Journal of Experimental & Clinical Cancer Research volume 32, Article number: 42 (2013) Cite this article

The Original Article was published on 11 September 2012

Correction

After the publication of this work[1], we noticed that we had incorrectly used the term ‘OGX-011’. All instances of OGX-011 in the manuscript should be changed to ‘ASO-CLU’, apart from the last paragraph in the Introduction section which should remain as published.

We also noticed in the first sentence of the second paragraph of the Materials and methods section we mistakenly stated that OGX-011 (ASO-CLU) was purchased from OncoGenex Technologies. As ASO-CLU is currently in the clinical testing phase, it is not available for sale from OncoGenex Technologies. The corrected sentence should read:

ASO-CLU was acquired from OncoGenex Technologies.

We apologise to the readers and OncoGenex Technologies for this oversight and any negative effects that may have resulted from it.

References

  1. Tang Y, Liu F, Zheng C, Sun S, Jiang Y: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. J Exp Clin Cancer Res. 2012, 31: 73-10.1186/1756-9966-31-73.

    Article  CAS  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Pancreatic Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China

      Yong Tang & Fenghua Liu

    2. Department of general surgery,the affiliated hospital of Jinan central hospital, Shandong university, No105, Jiefang Road, District Lixia, Jinan, 250013, R. P. China

      Chunning Zheng, Shaochuan Sun & Yingsheng Jiang

    Authors
    1. Yong Tang
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Fenghua Liu
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Chunning Zheng
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Shaochuan Sun
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Yingsheng Jiang
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Shaochuan Sun.

    Additional information

    The online version of the original article can be found at 10.1186/1756-9966-31-73

    Yong Tang, Fenghua Liu contributed equally to this work.

    Rights and permissions

    Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

    Reprints and Permissions

    About this article

    Cite this article

    Tang, Y., Liu, F., Zheng, C. et al. Erratum to: Knockdown of clusterin sensitizes pancreatic cancer cells to gemcitabine chemotherapy by ERK1/2 inactivation. J Exp Clin Cancer Res 32, 42 (2013). https://doi.org/10.1186/1756-9966-32-42

    Download citation

    • Received:

    • Accepted:

    • Published:

    • DOI: https://doi.org/10.1186/1756-9966-32-42

    Journal of Experimental & Clinical Cancer Research

    ISSN: 1756-9966

    Contact us